Bio4t2 announces first patient infused with CAR-T targeting solid tumors

/PRNewswire/ -- Bio4t2 dosed the first patient with T cells bearing a chimeric antigen receptor (CAR) that targets overexpression of BT-001 antigen present on...

Related Keywords

China ,United States ,Shanghai ,Farzad Haerizadeh ,Prnewswire Bio ,Jenny Bourbiel ,Bridgewest Group ,Laurence Cooper ,Executive Chairman ,Chief Scientific Officer ,Shanghai East ,Shanghai Artemed ,Bio4t2 ,